Global EGFR-TKI Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) are a class of targeted therapies designed to treat cancers driven by mutations in the EGFR gene, particularly non-small cell lung cancer (NSCLC).These drugs work by specifically inhibiting the tyrosine kinase activity of the EGFR.
The global EGFR-TKI market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “EGFR-TKI Industry Forecast” looks at past sales and reviews total world EGFR-TKI sales in 2023, providing a comprehensive analysis by region and market sector of projected EGFR-TKI sales for 2024 through 2030. With EGFR-TKI sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EGFR-TKI industry.
This Insight Report provides a comprehensive analysis of the global EGFR-TKI landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EGFR-TKI portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global EGFR-TKI market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EGFR-TKI and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EGFR-TKI.
United States market for EGFR-TKI is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for EGFR-TKI is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for EGFR-TKI is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key EGFR-TKI players cover AstraZeneca, Roche, Betta Pharma, Boehringer Ingelheim Pharmaceuticals, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of EGFR-TKI market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global EGFR-TKI market?
What factors are driving EGFR-TKI market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EGFR-TKI market opportunities vary by end market size?
How does EGFR-TKI break out by Type, by Application?
EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) are a class of targeted therapies designed to treat cancers driven by mutations in the EGFR gene, particularly non-small cell lung cancer (NSCLC).These drugs work by specifically inhibiting the tyrosine kinase activity of the EGFR.
The global EGFR-TKI market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “EGFR-TKI Industry Forecast” looks at past sales and reviews total world EGFR-TKI sales in 2023, providing a comprehensive analysis by region and market sector of projected EGFR-TKI sales for 2024 through 2030. With EGFR-TKI sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world EGFR-TKI industry.
This Insight Report provides a comprehensive analysis of the global EGFR-TKI landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on EGFR-TKI portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global EGFR-TKI market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for EGFR-TKI and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global EGFR-TKI.
United States market for EGFR-TKI is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for EGFR-TKI is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for EGFR-TKI is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key EGFR-TKI players cover AstraZeneca, Roche, Betta Pharma, Boehringer Ingelheim Pharmaceuticals, Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of EGFR-TKI market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Gefitinib
- Erlotinib
- Icotinib
- Afatinib
- Dacomitinib
- Osimertinib
- Aumolertinib
- Furmonertinib
- Lazertinib
- Other
- Hospital and Clinic
- Retail Pharmacies
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Roche
- Betta Pharma
- Boehringer Ingelheim Pharmaceuticals
- Pfizer
- Chengdu Brilliant Pharmaceuticals
- Hansoh Pharma
- ArriVent Biopharma
- Hanmi Pharmaceutical
- Johnson & Johnson
- Yuhan Corporation
- Shanghai Allist Pharmaceuticals
- Wanbang Biopharmaceuticals
- Beacon Pharma
- Drug International
- Teva
- Mylan
- Glenmark Pharmaceuticals
- Cipla
What is the 10-year outlook for the global EGFR-TKI market?
What factors are driving EGFR-TKI market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do EGFR-TKI market opportunities vary by end market size?
How does EGFR-TKI break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global EGFR-TKI Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for EGFR-TKI by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for EGFR-TKI by Country/Region, 2019, 2023 & 2030
2.2 EGFR-TKI Segment by Type
2.2.1 Gefitinib
2.2.2 Erlotinib
2.2.3 Icotinib
2.2.4 Afatinib
2.2.5 Dacomitinib
2.2.6 Osimertinib
2.2.7 Aumolertinib
2.2.8 Furmonertinib
2.2.9 Lazertinib
2.3 EGFR-TKI Sales by Type
2.3.1 Global EGFR-TKI Sales Market Share by Type (2019-2024)
2.3.2 Global EGFR-TKI Revenue and Market Share by Type (2019-2024)
2.3.3 Global EGFR-TKI Sale Price by Type (2019-2024)
2.4 EGFR-TKI Segment by Application
2.4.1 Hospital and Clinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 EGFR-TKI Sales by Application
2.5.1 Global EGFR-TKI Sale Market Share by Application (2019-2024)
2.5.2 Global EGFR-TKI Revenue and Market Share by Application (2019-2024)
2.5.3 Global EGFR-TKI Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global EGFR-TKI Breakdown Data by Company
3.1.1 Global EGFR-TKI Annual Sales by Company (2019-2024)
3.1.2 Global EGFR-TKI Sales Market Share by Company (2019-2024)
3.2 Global EGFR-TKI Annual Revenue by Company (2019-2024)
3.2.1 Global EGFR-TKI Revenue by Company (2019-2024)
3.2.2 Global EGFR-TKI Revenue Market Share by Company (2019-2024)
3.3 Global EGFR-TKI Sale Price by Company
3.4 Key Manufacturers EGFR-TKI Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EGFR-TKI Product Location Distribution
3.4.2 Players EGFR-TKI Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EGFR-TKI BY GEOGRAPHIC REGION
4.1 World Historic EGFR-TKI Market Size by Geographic Region (2019-2024)
4.1.1 Global EGFR-TKI Annual Sales by Geographic Region (2019-2024)
4.1.2 Global EGFR-TKI Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic EGFR-TKI Market Size by Country/Region (2019-2024)
4.2.1 Global EGFR-TKI Annual Sales by Country/Region (2019-2024)
4.2.2 Global EGFR-TKI Annual Revenue by Country/Region (2019-2024)
4.3 Americas EGFR-TKI Sales Growth
4.4 APAC EGFR-TKI Sales Growth
4.5 Europe EGFR-TKI Sales Growth
4.6 Middle East & Africa EGFR-TKI Sales Growth
5 AMERICAS
5.1 Americas EGFR-TKI Sales by Country
5.1.1 Americas EGFR-TKI Sales by Country (2019-2024)
5.1.2 Americas EGFR-TKI Revenue by Country (2019-2024)
5.2 Americas EGFR-TKI Sales by Type (2019-2024)
5.3 Americas EGFR-TKI Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EGFR-TKI Sales by Region
6.1.1 APAC EGFR-TKI Sales by Region (2019-2024)
6.1.2 APAC EGFR-TKI Revenue by Region (2019-2024)
6.2 APAC EGFR-TKI Sales by Type (2019-2024)
6.3 APAC EGFR-TKI Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe EGFR-TKI by Country
7.1.1 Europe EGFR-TKI Sales by Country (2019-2024)
7.1.2 Europe EGFR-TKI Revenue by Country (2019-2024)
7.2 Europe EGFR-TKI Sales by Type (2019-2024)
7.3 Europe EGFR-TKI Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa EGFR-TKI by Country
8.1.1 Middle East & Africa EGFR-TKI Sales by Country (2019-2024)
8.1.2 Middle East & Africa EGFR-TKI Revenue by Country (2019-2024)
8.2 Middle East & Africa EGFR-TKI Sales by Type (2019-2024)
8.3 Middle East & Africa EGFR-TKI Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EGFR-TKI
10.3 Manufacturing Process Analysis of EGFR-TKI
10.4 Industry Chain Structure of EGFR-TKI
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EGFR-TKI Distributors
11.3 EGFR-TKI Customer
12 WORLD FORECAST REVIEW FOR EGFR-TKI BY GEOGRAPHIC REGION
12.1 Global EGFR-TKI Market Size Forecast by Region
12.1.1 Global EGFR-TKI Forecast by Region (2025-2030)
12.1.2 Global EGFR-TKI Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global EGFR-TKI Forecast by Type (2025-2030)
12.7 Global EGFR-TKI Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca EGFR-TKI Product Portfolios and Specifications
13.1.3 AstraZeneca EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche EGFR-TKI Product Portfolios and Specifications
13.2.3 Roche EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Betta Pharma
13.3.1 Betta Pharma Company Information
13.3.2 Betta Pharma EGFR-TKI Product Portfolios and Specifications
13.3.3 Betta Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Betta Pharma Main Business Overview
13.3.5 Betta Pharma Latest Developments
13.4 Boehringer Ingelheim Pharmaceuticals
13.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
13.4.2 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
13.4.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer EGFR-TKI Product Portfolios and Specifications
13.5.3 Pfizer EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Chengdu Brilliant Pharmaceuticals
13.6.1 Chengdu Brilliant Pharmaceuticals Company Information
13.6.2 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Chengdu Brilliant Pharmaceuticals Main Business Overview
13.6.5 Chengdu Brilliant Pharmaceuticals Latest Developments
13.7 Hansoh Pharma
13.7.1 Hansoh Pharma Company Information
13.7.2 Hansoh Pharma EGFR-TKI Product Portfolios and Specifications
13.7.3 Hansoh Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hansoh Pharma Main Business Overview
13.7.5 Hansoh Pharma Latest Developments
13.8 ArriVent Biopharma
13.8.1 ArriVent Biopharma Company Information
13.8.2 ArriVent Biopharma EGFR-TKI Product Portfolios and Specifications
13.8.3 ArriVent Biopharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 ArriVent Biopharma Main Business Overview
13.8.5 ArriVent Biopharma Latest Developments
13.9 Hanmi Pharmaceutical
13.9.1 Hanmi Pharmaceutical Company Information
13.9.2 Hanmi Pharmaceutical EGFR-TKI Product Portfolios and Specifications
13.9.3 Hanmi Pharmaceutical EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hanmi Pharmaceutical Main Business Overview
13.9.5 Hanmi Pharmaceutical Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson EGFR-TKI Product Portfolios and Specifications
13.10.3 Johnson & Johnson EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 Yuhan Corporation
13.11.1 Yuhan Corporation Company Information
13.11.2 Yuhan Corporation EGFR-TKI Product Portfolios and Specifications
13.11.3 Yuhan Corporation EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Yuhan Corporation Main Business Overview
13.11.5 Yuhan Corporation Latest Developments
13.12 Shanghai Allist Pharmaceuticals
13.12.1 Shanghai Allist Pharmaceuticals Company Information
13.12.2 Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shanghai Allist Pharmaceuticals Main Business Overview
13.12.5 Shanghai Allist Pharmaceuticals Latest Developments
13.13 Wanbang Biopharmaceuticals
13.13.1 Wanbang Biopharmaceuticals Company Information
13.13.2 Wanbang Biopharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.13.3 Wanbang Biopharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Wanbang Biopharmaceuticals Main Business Overview
13.13.5 Wanbang Biopharmaceuticals Latest Developments
13.14 Beacon Pharma
13.14.1 Beacon Pharma Company Information
13.14.2 Beacon Pharma EGFR-TKI Product Portfolios and Specifications
13.14.3 Beacon Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Beacon Pharma Main Business Overview
13.14.5 Beacon Pharma Latest Developments
13.15 Drug International
13.15.1 Drug International Company Information
13.15.2 Drug International EGFR-TKI Product Portfolios and Specifications
13.15.3 Drug International EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Drug International Main Business Overview
13.15.5 Drug International Latest Developments
13.16 Teva
13.16.1 Teva Company Information
13.16.2 Teva EGFR-TKI Product Portfolios and Specifications
13.16.3 Teva EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Teva Main Business Overview
13.16.5 Teva Latest Developments
13.17 Mylan
13.17.1 Mylan Company Information
13.17.2 Mylan EGFR-TKI Product Portfolios and Specifications
13.17.3 Mylan EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Mylan Main Business Overview
13.17.5 Mylan Latest Developments
13.18 Glenmark Pharmaceuticals
13.18.1 Glenmark Pharmaceuticals Company Information
13.18.2 Glenmark Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.18.3 Glenmark Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Glenmark Pharmaceuticals Main Business Overview
13.18.5 Glenmark Pharmaceuticals Latest Developments
13.19 Cipla
13.19.1 Cipla Company Information
13.19.2 Cipla EGFR-TKI Product Portfolios and Specifications
13.19.3 Cipla EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Cipla Main Business Overview
13.19.5 Cipla Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. EGFR-TKI Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. EGFR-TKI Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gefitinib
Table 4. Major Players of Erlotinib
Table 5. Major Players of Icotinib
Table 6. Major Players of Afatinib
Table 7. Major Players of Dacomitinib
Table 8. Major Players of Osimertinib
Table 9. Major Players of Aumolertinib
Table 10. Major Players ofFurmonertinib
Table 11. Major Players of Lazertinib
Table 12. Global EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 13. Global EGFR-TKI Sales Market Share byType (2019-2024)
Table 14. Global EGFR-TKI Revenue byType (2019-2024) & ($ million)
Table 15. Global EGFR-TKI Revenue Market Share byType (2019-2024)
Table 16. Global EGFR-TKI Sale Price byType (2019-2024) & (US$/Unit)
Table 17. Global EGFR-TKI Sale by Application (2019-2024) & (K Units)
Table 18. Global EGFR-TKI Sale Market Share by Application (2019-2024)
Table 19. Global EGFR-TKI Revenue by Application (2019-2024) & ($ million)
Table 20. Global EGFR-TKI Revenue Market Share by Application (2019-2024)
Table 21. Global EGFR-TKI Sale Price by Application (2019-2024) & (US$/Unit)
Table 22. Global EGFR-TKI Sales by Company (2019-2024) & (K Units)
Table 23. Global EGFR-TKI Sales Market Share by Company (2019-2024)
Table 24. Global EGFR-TKI Revenue by Company (2019-2024) & ($ millions)
Table 25. Global EGFR-TKI Revenue Market Share by Company (2019-2024)
Table 26. Global EGFR-TKI Sale Price by Company (2019-2024) & (US$/Unit)
Table 27. Key Manufacturers EGFR-TKI Producing Area Distribution and Sales Area
Table 28. Players EGFR-TKI Products Offered
Table 29. EGFR-TKI Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global EGFR-TKI Sales by Geographic Region (2019-2024) & (K Units)
Table 33. Global EGFR-TKI Sales Market Share Geographic Region (2019-2024)
Table 34. Global EGFR-TKI Revenue by Geographic Region (2019-2024) & ($ millions)
Table 35. Global EGFR-TKI Revenue Market Share by Geographic Region (2019-2024)
Table 36. Global EGFR-TKI Sales by Country/Region (2019-2024) & (K Units)
Table 37. Global EGFR-TKI Sales Market Share by Country/Region (2019-2024)
Table 38. Global EGFR-TKI Revenue by Country/Region (2019-2024) & ($ millions)
Table 39. Global EGFR-TKI Revenue Market Share by Country/Region (2019-2024)
Table 40. Americas EGFR-TKI Sales by Country (2019-2024) & (K Units)
Table 41. Americas EGFR-TKI Sales Market Share by Country (2019-2024)
Table 42. Americas EGFR-TKI Revenue by Country (2019-2024) & ($ millions)
Table 43. Americas EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 44. Americas EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 45. APAC EGFR-TKI Sales by Region (2019-2024) & (K Units)
Table 46. APAC EGFR-TKI Sales Market Share by Region (2019-2024)
Table 47. APAC EGFR-TKI Revenue by Region (2019-2024) & ($ millions)
Table 48. APAC EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 49. APAC EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 50. Europe EGFR-TKI Sales by Country (2019-2024) & (K Units)
Table 51. Europe EGFR-TKI Revenue by Country (2019-2024) & ($ millions)
Table 52. Europe EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 53. Europe EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa EGFR-TKI Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa EGFR-TKI Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 57. Middle East & Africa EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of EGFR-TKI
Table 59. Key Market Challenges & Risks of EGFR-TKI
Table 60. Key IndustryTrends of EGFR-TKI
Table 61. EGFR-TKI Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. EGFR-TKI Distributors List
Table 64. EGFR-TKI Customer List
Table 65. Global EGFR-TKI SalesForecast by Region (2025-2030) & (K Units)
Table 66. Global EGFR-TKI RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Americas EGFR-TKI SalesForecast by Country (2025-2030) & (K Units)
Table 68. Americas EGFR-TKI Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. APAC EGFR-TKI SalesForecast by Region (2025-2030) & (K Units)
Table 70. APAC EGFR-TKI Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 71. Europe EGFR-TKI SalesForecast by Country (2025-2030) & (K Units)
Table 72. Europe EGFR-TKI RevenueForecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa EGFR-TKI SalesForecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa EGFR-TKI RevenueForecast by Country (2025-2030) & ($ millions)
Table 75. Global EGFR-TKI SalesForecast byType (2025-2030) & (K Units)
Table 76. Global EGFR-TKI RevenueForecast byType (2025-2030) & ($ millions)
Table 77. Global EGFR-TKI SalesForecast by Application (2025-2030) & (K Units)
Table 78. Global EGFR-TKI RevenueForecast by Application (2025-2030) & ($ millions)
Table 79. AstraZeneca Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 80. AstraZeneca EGFR-TKI Product Portfolios and Specifications
Table 81. AstraZeneca EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. AstraZeneca Main Business
Table 83. AstraZeneca Latest Developments
Table 84. Roche Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche EGFR-TKI Product Portfolios and Specifications
Table 86. Roche EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. Betta Pharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 90. Betta Pharma EGFR-TKI Product Portfolios and Specifications
Table 91. Betta Pharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Betta Pharma Main Business
Table 93. Betta Pharma Latest Developments
Table 94. Boehringer Ingelheim Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 96. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Boehringer Ingelheim Pharmaceuticals Main Business
Table 98. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 99. Pfizer Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer EGFR-TKI Product Portfolios and Specifications
Table 101. Pfizer EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. Chengdu Brilliant Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 105. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 106. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Chengdu Brilliant Pharmaceuticals Main Business
Table 108. Chengdu Brilliant Pharmaceuticals Latest Developments
Table 109. Hansoh Pharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 110. Hansoh Pharma EGFR-TKI Product Portfolios and Specifications
Table 111. Hansoh Pharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Hansoh Pharma Main Business
Table 113. Hansoh Pharma Latest Developments
Table 114. ArriVent Biopharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 115. ArriVent Biopharma EGFR-TKI Product Portfolios and Specifications
Table 116. ArriVent Biopharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. ArriVent Biopharma Main Business
Table 118. ArriVent Biopharma Latest Developments
Table 119. Hanmi Pharmaceutical Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 120. Hanmi Pharmaceutical EGFR-TKI Product Portfolios and Specifications
Table 121. Hanmi Pharmaceutical EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Hanmi Pharmaceutical Main Business
Table 123. Hanmi Pharmaceutical Latest Developments
Table 124. Johnson & Johnson Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 125. Johnson & Johnson EGFR-TKI Product Portfolios and Specifications
Table 126. Johnson & Johnson EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Johnson & Johnson Main Business
Table 128. Johnson & Johnson Latest Developments
Table 129. Yuhan Corporation Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 130. Yuhan Corporation EGFR-TKI Product Portfolios and Specifications
Table 131. Yuhan Corporation EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Yuhan Corporation Main Business
Table 133. Yuhan Corporation Latest Developments
Table 134. Shanghai Allist Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 136. Shanghai Allist Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Shanghai Allist Pharmaceuticals Main Business
Table 138. Shanghai Allist Pharmaceuticals Latest Developments
Table 139. Wanbang Biopharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 140. Wanbang Biopharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 141. Wanbang Biopharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Wanbang Biopharmaceuticals Main Business
Table 143. Wanbang Biopharmaceuticals Latest Developments
Table 144. Beacon Pharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 145. Beacon Pharma EGFR-TKI Product Portfolios and Specifications
Table 146. Beacon Pharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Beacon Pharma Main Business
Table 148. Beacon Pharma Latest Developments
Table 149. Drug International Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 150. Drug International EGFR-TKI Product Portfolios and Specifications
Table 151. Drug International EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Drug International Main Business
Table 153. Drug International Latest Developments
Table 154.Teva Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 155.Teva EGFR-TKI Product Portfolios and Specifications
Table 156.Teva EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157.Teva Main Business
Table 158.Teva Latest Developments
Table 159. Mylan Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 160. Mylan EGFR-TKI Product Portfolios and Specifications
Table 161. Mylan EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Mylan Main Business
Table 163. Mylan Latest Developments
Table 164. Glenmark Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 165. Glenmark Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 166. Glenmark Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 167. Glenmark Pharmaceuticals Main Business
Table 168. Glenmark Pharmaceuticals Latest Developments
Table 169. Cipla Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 170. Cipla EGFR-TKI Product Portfolios and Specifications
Table 171. Cipla EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 172. Cipla Main Business
Table 173. Cipla Latest Developments
LIST OFFIGURES
Figure 1. Picture of EGFR-TKI
Figure 2. EGFR-TKI Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EGFR-TKI Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global EGFR-TKI Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. EGFR-TKI Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. EGFR-TKI Sales Market Share by Country/Region (2023)
Figure 10. EGFR-TKI Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Gefitinib
Figure 12. Product Picture of Erlotinib
Figure 13. Product Picture of Icotinib
Figure 14. Product Picture of Afatinib
Figure 15. Product Picture of Dacomitinib
Figure 16. Product Picture of Osimertinib
Figure 17. Product Picture of Aumolertinib
Figure 18. Product Picture ofFurmonertinib
Figure 19. Product Picture of Lazertinib
Figure 20. Global EGFR-TKI Sales Market Share byType in 2023
Figure 21. Global EGFR-TKI Revenue Market Share byType (2019-2024)
Figure 22. EGFR-TKI Consumed in Hospital and Clinic
Figure 23. Global EGFR-TKI Market: Hospital and Clinic (2019-2024) & (K Units)
Figure 24. EGFR-TKI Consumed in Retail Pharmacies
Figure 25. Global EGFR-TKI Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 26. EGFR-TKI Consumed in Other
Figure 27. Global EGFR-TKI Market: Other (2019-2024) & (K Units)
Figure 28. Global EGFR-TKI Sale Market Share by Application (2023)
Figure 29. Global EGFR-TKI Revenue Market Share by Application in 2023
Figure 30. EGFR-TKI Sales by Company in 2023 (K Units)
Figure 31. Global EGFR-TKI Sales Market Share by Company in 2023
Figure 32. EGFR-TKI Revenue by Company in 2023 ($ millions)
Figure 33. Global EGFR-TKI Revenue Market Share by Company in 2023
Figure 34. Global EGFR-TKI Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global EGFR-TKI Revenue Market Share by Geographic Region in 2023
Figure 36. Americas EGFR-TKI Sales 2019-2024 (K Units)
Figure 37. Americas EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 38. APAC EGFR-TKI Sales 2019-2024 (K Units)
Figure 39. APAC EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 40. Europe EGFR-TKI Sales 2019-2024 (K Units)
Figure 41. Europe EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 42. Middle East & Africa EGFR-TKI Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 44. Americas EGFR-TKI Sales Market Share by Country in 2023
Figure 45. Americas EGFR-TKI Revenue Market Share by Country (2019-2024)
Figure 46. Americas EGFR-TKI Sales Market Share byType (2019-2024)
Figure 47. Americas EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 48. United States EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 49. Canada EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 50. Mexico EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 51. Brazil EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 52. APAC EGFR-TKI Sales Market Share by Region in 2023
Figure 53. APAC EGFR-TKI Revenue Market Share by Region (2019-2024)
Figure 54. APAC EGFR-TKI Sales Market Share byType (2019-2024)
Figure 55. APAC EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 56. China EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 57. Japan EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 58. South Korea EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 59. Southeast Asia EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 60. India EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 61. Australia EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 62. ChinaTaiwan EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 63. Europe EGFR-TKI Sales Market Share by Country in 2023
Figure 64. Europe EGFR-TKI Revenue Market Share by Country (2019-2024)
Figure 65. Europe EGFR-TKI Sales Market Share byType (2019-2024)
Figure 66. Europe EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 67. Germany EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 68.France EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 69. UK EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 70. Italy EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 71. Russia EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 72. Middle East & Africa EGFR-TKI Sales Market Share by Country (2019-2024)
Figure 73. Middle East & Africa EGFR-TKI Sales Market Share byType (2019-2024)
Figure 74. Middle East & Africa EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 75. Egypt EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 76. South Africa EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 77. Israel EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 78.Turkey EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 79. GCC Countries EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of EGFR-TKI in 2023
Figure 81. Manufacturing Process Analysis of EGFR-TKI
Figure 82. Industry Chain Structure of EGFR-TKI
Figure 83. Channels of Distribution
Figure 84. Global EGFR-TKI Sales MarketForecast by Region (2025-2030)
Figure 85. Global EGFR-TKI Revenue Market ShareForecast by Region (2025-2030)
Figure 86. Global EGFR-TKI Sales Market ShareForecast byType (2025-2030)
Figure 87. Global EGFR-TKI Revenue Market ShareForecast byType (2025-2030)
Figure 88. Global EGFR-TKI Sales Market ShareForecast by Application (2025-2030)
Figure 89. Global EGFR-TKI Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global EGFR-TKI Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for EGFR-TKI by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for EGFR-TKI by Country/Region, 2019, 2023 & 2030
2.2 EGFR-TKI Segment by Type
2.2.1 Gefitinib
2.2.2 Erlotinib
2.2.3 Icotinib
2.2.4 Afatinib
2.2.5 Dacomitinib
2.2.6 Osimertinib
2.2.7 Aumolertinib
2.2.8 Furmonertinib
2.2.9 Lazertinib
2.3 EGFR-TKI Sales by Type
2.3.1 Global EGFR-TKI Sales Market Share by Type (2019-2024)
2.3.2 Global EGFR-TKI Revenue and Market Share by Type (2019-2024)
2.3.3 Global EGFR-TKI Sale Price by Type (2019-2024)
2.4 EGFR-TKI Segment by Application
2.4.1 Hospital and Clinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 EGFR-TKI Sales by Application
2.5.1 Global EGFR-TKI Sale Market Share by Application (2019-2024)
2.5.2 Global EGFR-TKI Revenue and Market Share by Application (2019-2024)
2.5.3 Global EGFR-TKI Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global EGFR-TKI Breakdown Data by Company
3.1.1 Global EGFR-TKI Annual Sales by Company (2019-2024)
3.1.2 Global EGFR-TKI Sales Market Share by Company (2019-2024)
3.2 Global EGFR-TKI Annual Revenue by Company (2019-2024)
3.2.1 Global EGFR-TKI Revenue by Company (2019-2024)
3.2.2 Global EGFR-TKI Revenue Market Share by Company (2019-2024)
3.3 Global EGFR-TKI Sale Price by Company
3.4 Key Manufacturers EGFR-TKI Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers EGFR-TKI Product Location Distribution
3.4.2 Players EGFR-TKI Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EGFR-TKI BY GEOGRAPHIC REGION
4.1 World Historic EGFR-TKI Market Size by Geographic Region (2019-2024)
4.1.1 Global EGFR-TKI Annual Sales by Geographic Region (2019-2024)
4.1.2 Global EGFR-TKI Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic EGFR-TKI Market Size by Country/Region (2019-2024)
4.2.1 Global EGFR-TKI Annual Sales by Country/Region (2019-2024)
4.2.2 Global EGFR-TKI Annual Revenue by Country/Region (2019-2024)
4.3 Americas EGFR-TKI Sales Growth
4.4 APAC EGFR-TKI Sales Growth
4.5 Europe EGFR-TKI Sales Growth
4.6 Middle East & Africa EGFR-TKI Sales Growth
5 AMERICAS
5.1 Americas EGFR-TKI Sales by Country
5.1.1 Americas EGFR-TKI Sales by Country (2019-2024)
5.1.2 Americas EGFR-TKI Revenue by Country (2019-2024)
5.2 Americas EGFR-TKI Sales by Type (2019-2024)
5.3 Americas EGFR-TKI Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC EGFR-TKI Sales by Region
6.1.1 APAC EGFR-TKI Sales by Region (2019-2024)
6.1.2 APAC EGFR-TKI Revenue by Region (2019-2024)
6.2 APAC EGFR-TKI Sales by Type (2019-2024)
6.3 APAC EGFR-TKI Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe EGFR-TKI by Country
7.1.1 Europe EGFR-TKI Sales by Country (2019-2024)
7.1.2 Europe EGFR-TKI Revenue by Country (2019-2024)
7.2 Europe EGFR-TKI Sales by Type (2019-2024)
7.3 Europe EGFR-TKI Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa EGFR-TKI by Country
8.1.1 Middle East & Africa EGFR-TKI Sales by Country (2019-2024)
8.1.2 Middle East & Africa EGFR-TKI Revenue by Country (2019-2024)
8.2 Middle East & Africa EGFR-TKI Sales by Type (2019-2024)
8.3 Middle East & Africa EGFR-TKI Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of EGFR-TKI
10.3 Manufacturing Process Analysis of EGFR-TKI
10.4 Industry Chain Structure of EGFR-TKI
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 EGFR-TKI Distributors
11.3 EGFR-TKI Customer
12 WORLD FORECAST REVIEW FOR EGFR-TKI BY GEOGRAPHIC REGION
12.1 Global EGFR-TKI Market Size Forecast by Region
12.1.1 Global EGFR-TKI Forecast by Region (2025-2030)
12.1.2 Global EGFR-TKI Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global EGFR-TKI Forecast by Type (2025-2030)
12.7 Global EGFR-TKI Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca EGFR-TKI Product Portfolios and Specifications
13.1.3 AstraZeneca EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche EGFR-TKI Product Portfolios and Specifications
13.2.3 Roche EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Betta Pharma
13.3.1 Betta Pharma Company Information
13.3.2 Betta Pharma EGFR-TKI Product Portfolios and Specifications
13.3.3 Betta Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Betta Pharma Main Business Overview
13.3.5 Betta Pharma Latest Developments
13.4 Boehringer Ingelheim Pharmaceuticals
13.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
13.4.2 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
13.4.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer EGFR-TKI Product Portfolios and Specifications
13.5.3 Pfizer EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Chengdu Brilliant Pharmaceuticals
13.6.1 Chengdu Brilliant Pharmaceuticals Company Information
13.6.2 Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.6.3 Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Chengdu Brilliant Pharmaceuticals Main Business Overview
13.6.5 Chengdu Brilliant Pharmaceuticals Latest Developments
13.7 Hansoh Pharma
13.7.1 Hansoh Pharma Company Information
13.7.2 Hansoh Pharma EGFR-TKI Product Portfolios and Specifications
13.7.3 Hansoh Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Hansoh Pharma Main Business Overview
13.7.5 Hansoh Pharma Latest Developments
13.8 ArriVent Biopharma
13.8.1 ArriVent Biopharma Company Information
13.8.2 ArriVent Biopharma EGFR-TKI Product Portfolios and Specifications
13.8.3 ArriVent Biopharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 ArriVent Biopharma Main Business Overview
13.8.5 ArriVent Biopharma Latest Developments
13.9 Hanmi Pharmaceutical
13.9.1 Hanmi Pharmaceutical Company Information
13.9.2 Hanmi Pharmaceutical EGFR-TKI Product Portfolios and Specifications
13.9.3 Hanmi Pharmaceutical EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Hanmi Pharmaceutical Main Business Overview
13.9.5 Hanmi Pharmaceutical Latest Developments
13.10 Johnson & Johnson
13.10.1 Johnson & Johnson Company Information
13.10.2 Johnson & Johnson EGFR-TKI Product Portfolios and Specifications
13.10.3 Johnson & Johnson EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Johnson & Johnson Main Business Overview
13.10.5 Johnson & Johnson Latest Developments
13.11 Yuhan Corporation
13.11.1 Yuhan Corporation Company Information
13.11.2 Yuhan Corporation EGFR-TKI Product Portfolios and Specifications
13.11.3 Yuhan Corporation EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Yuhan Corporation Main Business Overview
13.11.5 Yuhan Corporation Latest Developments
13.12 Shanghai Allist Pharmaceuticals
13.12.1 Shanghai Allist Pharmaceuticals Company Information
13.12.2 Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.12.3 Shanghai Allist Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shanghai Allist Pharmaceuticals Main Business Overview
13.12.5 Shanghai Allist Pharmaceuticals Latest Developments
13.13 Wanbang Biopharmaceuticals
13.13.1 Wanbang Biopharmaceuticals Company Information
13.13.2 Wanbang Biopharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.13.3 Wanbang Biopharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Wanbang Biopharmaceuticals Main Business Overview
13.13.5 Wanbang Biopharmaceuticals Latest Developments
13.14 Beacon Pharma
13.14.1 Beacon Pharma Company Information
13.14.2 Beacon Pharma EGFR-TKI Product Portfolios and Specifications
13.14.3 Beacon Pharma EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Beacon Pharma Main Business Overview
13.14.5 Beacon Pharma Latest Developments
13.15 Drug International
13.15.1 Drug International Company Information
13.15.2 Drug International EGFR-TKI Product Portfolios and Specifications
13.15.3 Drug International EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Drug International Main Business Overview
13.15.5 Drug International Latest Developments
13.16 Teva
13.16.1 Teva Company Information
13.16.2 Teva EGFR-TKI Product Portfolios and Specifications
13.16.3 Teva EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Teva Main Business Overview
13.16.5 Teva Latest Developments
13.17 Mylan
13.17.1 Mylan Company Information
13.17.2 Mylan EGFR-TKI Product Portfolios and Specifications
13.17.3 Mylan EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Mylan Main Business Overview
13.17.5 Mylan Latest Developments
13.18 Glenmark Pharmaceuticals
13.18.1 Glenmark Pharmaceuticals Company Information
13.18.2 Glenmark Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
13.18.3 Glenmark Pharmaceuticals EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Glenmark Pharmaceuticals Main Business Overview
13.18.5 Glenmark Pharmaceuticals Latest Developments
13.19 Cipla
13.19.1 Cipla Company Information
13.19.2 Cipla EGFR-TKI Product Portfolios and Specifications
13.19.3 Cipla EGFR-TKI Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Cipla Main Business Overview
13.19.5 Cipla Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. EGFR-TKI Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. EGFR-TKI Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Gefitinib
Table 4. Major Players of Erlotinib
Table 5. Major Players of Icotinib
Table 6. Major Players of Afatinib
Table 7. Major Players of Dacomitinib
Table 8. Major Players of Osimertinib
Table 9. Major Players of Aumolertinib
Table 10. Major Players ofFurmonertinib
Table 11. Major Players of Lazertinib
Table 12. Global EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 13. Global EGFR-TKI Sales Market Share byType (2019-2024)
Table 14. Global EGFR-TKI Revenue byType (2019-2024) & ($ million)
Table 15. Global EGFR-TKI Revenue Market Share byType (2019-2024)
Table 16. Global EGFR-TKI Sale Price byType (2019-2024) & (US$/Unit)
Table 17. Global EGFR-TKI Sale by Application (2019-2024) & (K Units)
Table 18. Global EGFR-TKI Sale Market Share by Application (2019-2024)
Table 19. Global EGFR-TKI Revenue by Application (2019-2024) & ($ million)
Table 20. Global EGFR-TKI Revenue Market Share by Application (2019-2024)
Table 21. Global EGFR-TKI Sale Price by Application (2019-2024) & (US$/Unit)
Table 22. Global EGFR-TKI Sales by Company (2019-2024) & (K Units)
Table 23. Global EGFR-TKI Sales Market Share by Company (2019-2024)
Table 24. Global EGFR-TKI Revenue by Company (2019-2024) & ($ millions)
Table 25. Global EGFR-TKI Revenue Market Share by Company (2019-2024)
Table 26. Global EGFR-TKI Sale Price by Company (2019-2024) & (US$/Unit)
Table 27. Key Manufacturers EGFR-TKI Producing Area Distribution and Sales Area
Table 28. Players EGFR-TKI Products Offered
Table 29. EGFR-TKI Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 30. New Products and Potential Entrants
Table 31. Market M&A Activity & Strategy
Table 32. Global EGFR-TKI Sales by Geographic Region (2019-2024) & (K Units)
Table 33. Global EGFR-TKI Sales Market Share Geographic Region (2019-2024)
Table 34. Global EGFR-TKI Revenue by Geographic Region (2019-2024) & ($ millions)
Table 35. Global EGFR-TKI Revenue Market Share by Geographic Region (2019-2024)
Table 36. Global EGFR-TKI Sales by Country/Region (2019-2024) & (K Units)
Table 37. Global EGFR-TKI Sales Market Share by Country/Region (2019-2024)
Table 38. Global EGFR-TKI Revenue by Country/Region (2019-2024) & ($ millions)
Table 39. Global EGFR-TKI Revenue Market Share by Country/Region (2019-2024)
Table 40. Americas EGFR-TKI Sales by Country (2019-2024) & (K Units)
Table 41. Americas EGFR-TKI Sales Market Share by Country (2019-2024)
Table 42. Americas EGFR-TKI Revenue by Country (2019-2024) & ($ millions)
Table 43. Americas EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 44. Americas EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 45. APAC EGFR-TKI Sales by Region (2019-2024) & (K Units)
Table 46. APAC EGFR-TKI Sales Market Share by Region (2019-2024)
Table 47. APAC EGFR-TKI Revenue by Region (2019-2024) & ($ millions)
Table 48. APAC EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 49. APAC EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 50. Europe EGFR-TKI Sales by Country (2019-2024) & (K Units)
Table 51. Europe EGFR-TKI Revenue by Country (2019-2024) & ($ millions)
Table 52. Europe EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 53. Europe EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa EGFR-TKI Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa EGFR-TKI Revenue Market Share by Country (2019-2024)
Table 56. Middle East & Africa EGFR-TKI Sales byType (2019-2024) & (K Units)
Table 57. Middle East & Africa EGFR-TKI Sales by Application (2019-2024) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of EGFR-TKI
Table 59. Key Market Challenges & Risks of EGFR-TKI
Table 60. Key IndustryTrends of EGFR-TKI
Table 61. EGFR-TKI Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. EGFR-TKI Distributors List
Table 64. EGFR-TKI Customer List
Table 65. Global EGFR-TKI SalesForecast by Region (2025-2030) & (K Units)
Table 66. Global EGFR-TKI RevenueForecast by Region (2025-2030) & ($ millions)
Table 67. Americas EGFR-TKI SalesForecast by Country (2025-2030) & (K Units)
Table 68. Americas EGFR-TKI Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. APAC EGFR-TKI SalesForecast by Region (2025-2030) & (K Units)
Table 70. APAC EGFR-TKI Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 71. Europe EGFR-TKI SalesForecast by Country (2025-2030) & (K Units)
Table 72. Europe EGFR-TKI RevenueForecast by Country (2025-2030) & ($ millions)
Table 73. Middle East & Africa EGFR-TKI SalesForecast by Country (2025-2030) & (K Units)
Table 74. Middle East & Africa EGFR-TKI RevenueForecast by Country (2025-2030) & ($ millions)
Table 75. Global EGFR-TKI SalesForecast byType (2025-2030) & (K Units)
Table 76. Global EGFR-TKI RevenueForecast byType (2025-2030) & ($ millions)
Table 77. Global EGFR-TKI SalesForecast by Application (2025-2030) & (K Units)
Table 78. Global EGFR-TKI RevenueForecast by Application (2025-2030) & ($ millions)
Table 79. AstraZeneca Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 80. AstraZeneca EGFR-TKI Product Portfolios and Specifications
Table 81. AstraZeneca EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 82. AstraZeneca Main Business
Table 83. AstraZeneca Latest Developments
Table 84. Roche Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 85. Roche EGFR-TKI Product Portfolios and Specifications
Table 86. Roche EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Roche Main Business
Table 88. Roche Latest Developments
Table 89. Betta Pharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 90. Betta Pharma EGFR-TKI Product Portfolios and Specifications
Table 91. Betta Pharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Betta Pharma Main Business
Table 93. Betta Pharma Latest Developments
Table 94. Boehringer Ingelheim Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 95. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 96. Boehringer Ingelheim Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Boehringer Ingelheim Pharmaceuticals Main Business
Table 98. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 99. Pfizer Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 100. Pfizer EGFR-TKI Product Portfolios and Specifications
Table 101. Pfizer EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 102. Pfizer Main Business
Table 103. Pfizer Latest Developments
Table 104. Chengdu Brilliant Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 105. Chengdu Brilliant Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 106. Chengdu Brilliant Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 107. Chengdu Brilliant Pharmaceuticals Main Business
Table 108. Chengdu Brilliant Pharmaceuticals Latest Developments
Table 109. Hansoh Pharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 110. Hansoh Pharma EGFR-TKI Product Portfolios and Specifications
Table 111. Hansoh Pharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 112. Hansoh Pharma Main Business
Table 113. Hansoh Pharma Latest Developments
Table 114. ArriVent Biopharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 115. ArriVent Biopharma EGFR-TKI Product Portfolios and Specifications
Table 116. ArriVent Biopharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 117. ArriVent Biopharma Main Business
Table 118. ArriVent Biopharma Latest Developments
Table 119. Hanmi Pharmaceutical Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 120. Hanmi Pharmaceutical EGFR-TKI Product Portfolios and Specifications
Table 121. Hanmi Pharmaceutical EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 122. Hanmi Pharmaceutical Main Business
Table 123. Hanmi Pharmaceutical Latest Developments
Table 124. Johnson & Johnson Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 125. Johnson & Johnson EGFR-TKI Product Portfolios and Specifications
Table 126. Johnson & Johnson EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 127. Johnson & Johnson Main Business
Table 128. Johnson & Johnson Latest Developments
Table 129. Yuhan Corporation Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 130. Yuhan Corporation EGFR-TKI Product Portfolios and Specifications
Table 131. Yuhan Corporation EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 132. Yuhan Corporation Main Business
Table 133. Yuhan Corporation Latest Developments
Table 134. Shanghai Allist Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Allist Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 136. Shanghai Allist Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 137. Shanghai Allist Pharmaceuticals Main Business
Table 138. Shanghai Allist Pharmaceuticals Latest Developments
Table 139. Wanbang Biopharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 140. Wanbang Biopharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 141. Wanbang Biopharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 142. Wanbang Biopharmaceuticals Main Business
Table 143. Wanbang Biopharmaceuticals Latest Developments
Table 144. Beacon Pharma Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 145. Beacon Pharma EGFR-TKI Product Portfolios and Specifications
Table 146. Beacon Pharma EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 147. Beacon Pharma Main Business
Table 148. Beacon Pharma Latest Developments
Table 149. Drug International Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 150. Drug International EGFR-TKI Product Portfolios and Specifications
Table 151. Drug International EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 152. Drug International Main Business
Table 153. Drug International Latest Developments
Table 154.Teva Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 155.Teva EGFR-TKI Product Portfolios and Specifications
Table 156.Teva EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 157.Teva Main Business
Table 158.Teva Latest Developments
Table 159. Mylan Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 160. Mylan EGFR-TKI Product Portfolios and Specifications
Table 161. Mylan EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 162. Mylan Main Business
Table 163. Mylan Latest Developments
Table 164. Glenmark Pharmaceuticals Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 165. Glenmark Pharmaceuticals EGFR-TKI Product Portfolios and Specifications
Table 166. Glenmark Pharmaceuticals EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 167. Glenmark Pharmaceuticals Main Business
Table 168. Glenmark Pharmaceuticals Latest Developments
Table 169. Cipla Basic Information, EGFR-TKI Manufacturing Base, Sales Area and Its Competitors
Table 170. Cipla EGFR-TKI Product Portfolios and Specifications
Table 171. Cipla EGFR-TKI Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 172. Cipla Main Business
Table 173. Cipla Latest Developments
LIST OFFIGURES
Figure 1. Picture of EGFR-TKI
Figure 2. EGFR-TKI Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global EGFR-TKI Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global EGFR-TKI Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. EGFR-TKI Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. EGFR-TKI Sales Market Share by Country/Region (2023)
Figure 10. EGFR-TKI Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Gefitinib
Figure 12. Product Picture of Erlotinib
Figure 13. Product Picture of Icotinib
Figure 14. Product Picture of Afatinib
Figure 15. Product Picture of Dacomitinib
Figure 16. Product Picture of Osimertinib
Figure 17. Product Picture of Aumolertinib
Figure 18. Product Picture ofFurmonertinib
Figure 19. Product Picture of Lazertinib
Figure 20. Global EGFR-TKI Sales Market Share byType in 2023
Figure 21. Global EGFR-TKI Revenue Market Share byType (2019-2024)
Figure 22. EGFR-TKI Consumed in Hospital and Clinic
Figure 23. Global EGFR-TKI Market: Hospital and Clinic (2019-2024) & (K Units)
Figure 24. EGFR-TKI Consumed in Retail Pharmacies
Figure 25. Global EGFR-TKI Market: Retail Pharmacies (2019-2024) & (K Units)
Figure 26. EGFR-TKI Consumed in Other
Figure 27. Global EGFR-TKI Market: Other (2019-2024) & (K Units)
Figure 28. Global EGFR-TKI Sale Market Share by Application (2023)
Figure 29. Global EGFR-TKI Revenue Market Share by Application in 2023
Figure 30. EGFR-TKI Sales by Company in 2023 (K Units)
Figure 31. Global EGFR-TKI Sales Market Share by Company in 2023
Figure 32. EGFR-TKI Revenue by Company in 2023 ($ millions)
Figure 33. Global EGFR-TKI Revenue Market Share by Company in 2023
Figure 34. Global EGFR-TKI Sales Market Share by Geographic Region (2019-2024)
Figure 35. Global EGFR-TKI Revenue Market Share by Geographic Region in 2023
Figure 36. Americas EGFR-TKI Sales 2019-2024 (K Units)
Figure 37. Americas EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 38. APAC EGFR-TKI Sales 2019-2024 (K Units)
Figure 39. APAC EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 40. Europe EGFR-TKI Sales 2019-2024 (K Units)
Figure 41. Europe EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 42. Middle East & Africa EGFR-TKI Sales 2019-2024 (K Units)
Figure 43. Middle East & Africa EGFR-TKI Revenue 2019-2024 ($ millions)
Figure 44. Americas EGFR-TKI Sales Market Share by Country in 2023
Figure 45. Americas EGFR-TKI Revenue Market Share by Country (2019-2024)
Figure 46. Americas EGFR-TKI Sales Market Share byType (2019-2024)
Figure 47. Americas EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 48. United States EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 49. Canada EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 50. Mexico EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 51. Brazil EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 52. APAC EGFR-TKI Sales Market Share by Region in 2023
Figure 53. APAC EGFR-TKI Revenue Market Share by Region (2019-2024)
Figure 54. APAC EGFR-TKI Sales Market Share byType (2019-2024)
Figure 55. APAC EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 56. China EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 57. Japan EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 58. South Korea EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 59. Southeast Asia EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 60. India EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 61. Australia EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 62. ChinaTaiwan EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 63. Europe EGFR-TKI Sales Market Share by Country in 2023
Figure 64. Europe EGFR-TKI Revenue Market Share by Country (2019-2024)
Figure 65. Europe EGFR-TKI Sales Market Share byType (2019-2024)
Figure 66. Europe EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 67. Germany EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 68.France EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 69. UK EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 70. Italy EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 71. Russia EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 72. Middle East & Africa EGFR-TKI Sales Market Share by Country (2019-2024)
Figure 73. Middle East & Africa EGFR-TKI Sales Market Share byType (2019-2024)
Figure 74. Middle East & Africa EGFR-TKI Sales Market Share by Application (2019-2024)
Figure 75. Egypt EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 76. South Africa EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 77. Israel EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 78.Turkey EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 79. GCC Countries EGFR-TKI Revenue Growth 2019-2024 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of EGFR-TKI in 2023
Figure 81. Manufacturing Process Analysis of EGFR-TKI
Figure 82. Industry Chain Structure of EGFR-TKI
Figure 83. Channels of Distribution
Figure 84. Global EGFR-TKI Sales MarketForecast by Region (2025-2030)
Figure 85. Global EGFR-TKI Revenue Market ShareForecast by Region (2025-2030)
Figure 86. Global EGFR-TKI Sales Market ShareForecast byType (2025-2030)
Figure 87. Global EGFR-TKI Revenue Market ShareForecast byType (2025-2030)
Figure 88. Global EGFR-TKI Sales Market ShareForecast by Application (2025-2030)
Figure 89. Global EGFR-TKI Revenue Market ShareForecast by Application (2025-2030)
